Medicina 3. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer‘s acetate in severe sepsis. N Engl J Med 2012; 367: 124-34. 4. Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management. Anesthesiology 2008; 109: 723-40.
5. Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96: 1453-9, table. 6. Mahmood A, Gosling P, Vohra RK. Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatine during aortic aneurysm surgery. Br J Surg 2007; 94: 427-33. 7. Sakr Y, Payen D, Reinhart K, et al. Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 2007; 98: 216-24.
8. Godet G, Lehot JJ, Janvier G, et al. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial. European Journal of Anaesthesiology (EJA) 2008; 25. 9. Boussekey N, Darmon R, Langlois J, et al. Resuscitation with low volume hydroxyethylstarch 130 kDa/0.4 is not associated with acute kidney injury. Critical Care 2010; 14: R40.
Resuscitation of Severe Trauma). British Journal of Anaesthesia 2011; 107: 693-702.
11. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012; 16: R94.
12. Madigan MC, Kemp CD, Johnson JC, Cotton BA. Secondary abdominal compartment syndrome after severe extremity injury: are early, aggressive fluid resuscitation strategies to blame? J Trauma 2008; 64: 280-5.
13. Brandstrup B, Tonnesen H, Beier-Holgersen R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial. Ann Surg 2003; 238: 641-8. 14. Malbrain ML, Chiumello D, Pelosi P, et al. Incidence and prognosis of intraabdominal hypertension in a mixed population of critically ill patients: a multiple-center epidemiological study. Crit Care Med 2005; 33: 315-22.
15. Vidal MG, Ruiz WJ, Gonzalez F, et al. Incidence and clinical effects of intra-abdominal hypertension in critically ill patients. Crit Care Med 2008; 36: 1823-31.
10. James MFM, Michell WL, Joubert IA, et al. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in
Zmanjšanje razširjenosti humanih virusov papiloma (HPV) med cepljenimi dekleti proti HPV v Združenih državah Amerike Alenka Trop Skaza
Ameriški avtorji so v juniju letošnjega leta v Journal of infectious diseases objavili zanimiv članek o razširjenosti HPV pri ženskah v starosti od 14 do 59 let (Reduction in human papillomavirus prevalence among young women following HPV vaccine introduction in the United States, National health and nutrition examination surveys, 2003–2010). Primerjali so razširjenost HPV v letih pred uvedbo cepljenja proti HPV (2003–2006) in po uvedbi cepljenja (obdobje 2007–2010). V vsaki skupini je bilo več kot 4.000 preiskovank. Brise materničnega vratu so preiskali na prisotnost 37 HPV. V ZDA je bilo rutinsko cepljenje s štirivalentnim cepivom proti HPV-okužbam za 11 do 12 let stara dekleta uvedeno v letu 2006, cepljenje je bilo omogočeno tudi dekletom, starim od 13 do 26 let. V letu 2010 je bilo popolno s Revija ISIS - Avgust/september 2013
67